Literature DB >> 17098443

14-3-3 protein binds to the low molecular weight neurofilament (NFL) mRNA 3' UTR.

Wei-Wen Ge1, Kathryn Volkening, Cheryl Leystra-Lantz, Howard Jaffe, Michael J Strong.   

Abstract

We have previously reported that altered stability of low molecular weight neurofilament (NFL) mRNA in lumbar spinal cord homogenates in amyotrophic lateral sclerosis (ALS) is associated with altered expression of trans-acting 3' UTR mRNA binding proteins. We have identified two hexanucleotide motifs as the main cis elements and, using LC/MS/MS of peptide digests of NFL 3' UTR interacting proteins from human spinal cord, observed that 14-3-3 proteins interact with these motifs. 14-3-3 beta, zeta, tau, gamma, and eta isoforms were found to be expressed in human spinal cord. Each isoform was expressed in vitro and shown to interact with NFL 3' UTR mRNA. Mutation of one or both motifs resulted in decreased 14-3-3 interaction, changes in predicted mRNA structure or alteration in stability of the mRNA. These data show a novel interaction for 14-3-3 with NFL mRNA, and suggests that 14-3-3 may play a role in regulating NFL mRNA stability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098443     DOI: 10.1016/j.mcn.2006.10.001

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  9 in total

1.  Delayed cell cycle progression in selenoprotein W-depleted cells is regulated by a mitogen-activated protein kinase kinase 4-p38/c-Jun NH2-terminal kinase-p53 pathway.

Authors:  Wayne Chris Hawkes; Zeynep Alkan
Journal:  J Biol Chem       Date:  2012-06-22       Impact factor: 5.157

2.  Overexpression of 14-3-3ζ Increases Brain Levels of C/EBP Homologous Protein CHOP.

Authors:  Gary P Brennan; Eva M Jimenez-Mateos; Amaya Sanz-Rodriguez; Claire M Mooney; Guri Tzivion; David C Henshall; Tobias Engel
Journal:  J Mol Neurosci       Date:  2015-02-18       Impact factor: 3.444

3.  Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models.

Authors:  Mohit Raja Jain; Wei-Wen Ge; Stella Elkabes; Hong Li
Journal:  Proteomics Clin Appl       Date:  2008-05-01       Impact factor: 3.494

Review 4.  The roles of intrinsic disorder-based liquid-liquid phase transitions in the "Dr. Jekyll-Mr. Hyde" behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Authors:  Vladimir N Uversky
Journal:  Autophagy       Date:  2017-12-17       Impact factor: 16.016

5.  Analysis of novel NEFL mRNA targeting microRNAs in amyotrophic lateral sclerosis.

Authors:  Muhammad Ishtiaq; Danae Campos-Melo; Kathryn Volkening; Michael J Strong
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

6.  Heat shock factor 1 over-expression protects against exposure of hydrophobic residues on mutant SOD1 and early mortality in a mouse model of amyotrophic lateral sclerosis.

Authors:  Pei-Yi Lin; Sharotka M Simon; Won Kyun Koh; Oluwarotimi Folorunso; C Samuel Umbaugh; Anson Pierce
Journal:  Mol Neurodegener       Date:  2013-11-21       Impact factor: 14.195

Review 7.  Neurofilament proteins in axonal regeneration and neurodegenerative diseases.

Authors:  Haitao Wang; Minfei Wu; Chuanjun Zhan; Enyuan Ma; Maoguang Yang; Xiaoyu Yang; Yingpu Li
Journal:  Neural Regen Res       Date:  2012-03-15       Impact factor: 5.135

Review 8.  Neuroprotective function of 14-3-3 proteins in neurodegeneration.

Authors:  Tadayuki Shimada; Alyson E Fournier; Kanato Yamagata
Journal:  Biomed Res Int       Date:  2013-12-02       Impact factor: 3.411

9.  Differentiation defects in primary motoneurons from a SMARD1 mouse model that are insensitive to treatment with low dose PEGylated IGF1.

Authors:  Frank Krieger; Friedrich Metzger; Sibylle Jablonka
Journal:  Rare Dis       Date:  2014-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.